AKT1 and colonic neoplasm: Son et al. reported that PSD inhibits the PI3K/AKT/mTOR signaling pathway, thereby inducing apoptosis, suppressing proliferation and angiogenesis, and demonstrating stronger anti-colon cancer activity than 5-fluorouracil in both in vitro and in vivo models [36].